Enumeral Biomedical Holdings, Inc.: 10-Q filed 2016-11-10
What Enumeral Biomedical Holdings, Inc. reported in its quarterly report filed 2016-11-10 (fiscal Q3 2016): 30 published measures, 87 facts as tagged in accession 0001615774-16-008157.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2016-11-10
- Fiscal period
- fiscal Q3 2016
- Accession
- 0001615774-16-008157 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Enumeral Biomedical Holdings, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 4,049,865 | USD | |
| At 2015-12-31 | 6,343,598 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 4,856,969 | USD | |
| At 2015-12-31 | 3,870,541 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | -807,104 | USD | |
| At 2015-12-31 | 2,473,057 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 1,893,414 | USD | |
| At 2015-12-31 | 3,596,262 | USD | |
| At 2015-09-30 | 5,940,491 | USD | |
| At 2014-12-31 | 10,460,117 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -1,260,850 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -4,163,459 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 618,284 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 2,881,059 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 1,133,299 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | -18,572,435 | USD | |
| At 2015-12-31 | -14,408,976 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 52,073,481 | shares | 92 |
| 2016-01-01 to 2016-09-30 | 52,071,933 | shares | 274 |
| 2015-07-01 to 2015-09-30 | 51,699,028 | shares | 92 |
| 2015-01-01 to 2015-09-30 | 51,648,800 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 52,073,481 | shares | 92 |
| 2016-01-01 to 2016-09-30 | 52,071,933 | shares | 274 |
| 2015-07-01 to 2015-09-30 | 52,986,588 | shares | 92 |
| 2015-01-01 to 2015-09-30 | 53,727,593 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -0.02 | USD/shares | 92 |
| 2016-01-01 to 2016-09-30 | -0.08 | USD/shares | 274 |
| 2015-07-01 to 2015-09-30 | 0.01 | USD/shares | 92 |
| 2015-01-01 to 2015-09-30 | 0.06 | USD/shares | 273 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -0.02 | USD/shares | 92 |
| 2016-01-01 to 2016-09-30 | -0.08 | USD/shares | 274 |
| 2015-07-01 to 2015-09-30 | 0.01 | USD/shares | 92 |
| 2015-01-01 to 2015-09-30 | 0.05 | USD/shares | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 1,031,192 | USD | |
| At 2015-12-31 | 1,511,493 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 280,976 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 883,298 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 184,775 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 477,666 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -1,518,480 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -5,235,433 | USD | 274 |
| 2015-07-01 to 2015-09-30 | -2,668,480 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -7,965,075 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 2,372,337 | USD | |
| At 2015-12-31 | 4,182,753 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 4,720,701 | USD | |
| At 2015-12-31 | 3,567,223 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 436,734 | USD | |
| At 2015-12-31 | 343,736 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 265,537 | USD | |
| At 2015-12-31 | 306,012 | USD |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 1,026,317 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 3,737,161 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 1,798,241 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 4,833,911 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 52,073,481 | shares | |
| At 2015-12-31 | 51,932,571 | shares |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 2,896,319 | USD | |
| At 2015-12-31 | 2,896,319 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 1,865,127 | USD | |
| At 2015-12-31 | 1,384,826 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 111,556 | USD | |
| At 2015-12-31 | 114,572 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 485,449 | USD | |
| At 2015-12-31 | 714,384 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -1,260,850 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -4,163,459 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 618,284 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 2,881,059 | USD | 273 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -1,260,850 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -4,163,459 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 618,284 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 2,890,836 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 812,974 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 3,752,512 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 1,354,064 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 4,271,024 | USD | 273 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 126,301 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 480,301 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 149,901 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 425,788 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 257,630 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 1,071,974 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 3,286,764 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 10,846,134 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | -40,475 | USD | 274 |
| 2015-01-01 to 2015-09-30 | 101,939 | USD | 273 |
Inspect the source
- Entity
- Enumeral Biomedical Holdings, Inc. / CIK 0001561551
- Captured
- SEC response SHA-256
6114205c55b99bc1ed9e32f69ccda777fafa1416a587c9f9d51a573f8a356bc0
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001561551.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))